September 29, 2014
Launched in the early 1990’s, the Rare Cancer Network (RCN) gathers, analyzes and publishes data on rare cancers and rare forms of common cancers. In two reports from the network’s first international symposium, published in Rare Tumors, founding partners Mirimanoff and Ozsahin describe the RCN’s achievements, ongoing studies and future collaborations.
With contributions from its 130 member investigators, the network has completed 54 studies, published 46 peer-reviewed articles and launched 14 new projects. In March this year, the RCN held its first international symposium during which it presented some of these studies. The RCN aims to gain better knowledge and understanding of rare cancers in efforts to improve therapeutic options and disease outcomes.